We just received data on a new analyst forecast for $KALV. Andrew Fein from HC Wainwright & Co. set a price target of 27.0 for KALV.
To track analyst ratings and price targets for $KALV, check out Quiver Quantitative's $KALV forecast page.
$KALV Price Targets
Multiple analysts have issued price targets for $KALV recently. We have seen 6 analysts offer price targets for $KALV in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Andrew Fein from HC Wainwright & Co. set a target price of $27.0 on 07/11/2025
- Jonathan Wolleben from JMP Securities set a target price of $27.0 on 07/08/2025
- Joseph Schwartz from Leerink Partners set a target price of $20.0 on 07/07/2025
- Serge Belanger from Needham set a target price of $28.0 on 04/08/2025
- Jonathan Wolleben from Citizens Capital Markets set a target price of $19.0 on 03/26/2025
- Debanjana Chatterjee from Jones Trading set a target price of $30.0 on 03/26/2025
$KALV Insider Trading Activity
$KALV insiders have traded $KALV stock on the open market 26 times in the past 6 months. Of those trades, 9 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $KALV stock by insiders over the last 6 months:
- HEALTHCARE CAPITAL PARTNERS III, L.P. VENROCK has made 9 purchases buying 361,212 shares for an estimated $3,322,933 and 0 sales.
- BENJAMIN L PALLEIKO (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 6 sales selling 65,728 shares for an estimated $915,284.
- CHRISTOPHER YEA (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 6 sales selling 41,612 shares for an estimated $599,557.
- PAUL K. AUDHYA (CHIEF MEDICAL OFFICER) has made 0 purchases and 5 sales selling 13,130 shares for an estimated $143,769.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KALV Hedge Fund Activity
We have seen 65 institutional investors add shares of $KALV stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOXER CAPITAL MANAGEMENT, LLC removed 1,590,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $18,348,600
- SILVERARC CAPITAL MANAGEMENT, LLC added 1,086,811 shares (+177.5%) to their portfolio in Q1 2025, for an estimated $12,541,798
- GREAT POINT PARTNERS LLC removed 772,636 shares (-43.2%) from their portfolio in Q1 2025, for an estimated $8,916,219
- PARKMAN HEALTHCARE PARTNERS LLC added 753,752 shares (+inf%) to their portfolio in Q1 2025, for an estimated $8,698,298
- STEMPOINT CAPITAL LP removed 605,966 shares (-61.0%) from their portfolio in Q1 2025, for an estimated $6,992,847
- SCHONFELD STRATEGIC ADVISORS LLC added 581,746 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,713,348
- VR ADVISER, LLC added 454,254 shares (+7.3%) to their portfolio in Q1 2025, for an estimated $5,242,091
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
